Faber, Erik B.
980  Ergebnisse:
Personensuche X
?
1

Screening through Lead Optimization of High Affinity, Allos..:

Faber, Erik B. ; Wang, Nan ; John, Kristen...
Journal of Medicinal Chemistry.  66 (2023)  3 - p. 1928-1940 , 2023
 
?
4

DFG-1 Binding: A New Residue for Developing Selective Kinas..:

Faber, Erik B. ; Georg, Gunda I.
Journal of Medicinal Chemistry.  63 (2020)  18 - p. 10221-10223 , 2020
 
?
7

Quantitative conformational profiling of kinase inhibitors ..:

Lake, Eric W. ; Muretta, Joseph M. ; Thompson, Andrew R....
Proceedings of the National Academy of Sciences of the United States of America.  115 (2018)  51 - p. E11894-E11903 , 2018
 
?
8

Quantitative conformational profiling of kinase inhibitors ..:

Lake, Eric W. ; Muretta, Joseph M. ; Thompson, Andrew R....
Proceedings of the National Academy of Sciences.  115 (2018)  51 - p. , 2018
 
?
10

Development of allosteric and selective CDK2 inhibitors for..:

Faber, Erik B ; Sun, Luxin ; Tang, Jian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239507/.  , 2023
 
?
 
?
 
?
14

Defining and Characterizing Frequent Attenders: Systematic ..:

Dip M. Shukla ; Erik B. Faber ; Brian Sick
https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1747&context=jpcrr.  , 2020
 
1-15